{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Livonia",
      "state": "MI",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77105",
      "recalling_firm": "The Harvard Drug Group",
      "address_1": "17177 N Laurel Park Dr Ste 233",
      "address_2": "",
      "postal_code": "48152-3951",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide and PR",
      "recall_number": "D-0692-2017",
      "product_description": "Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI  NDC 0904-6509-04",
      "product_quantity": "36,990 tablets",
      "reason_for_recall": "Superpotent Drug; out of specification results for assay (manufacturer)",
      "recall_initiation_date": "20161227",
      "center_classification_date": "20170502",
      "termination_date": "20170727",
      "report_date": "20170510",
      "code_info": "LOT: T-00601 Exp: 04-2017",
      "more_code_info": ""
    }
  ]
}